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ABSTRACT
Background: The transradial approach for percutaneous coronary 
intervention (PCI) is still not widely used in our country. We 
evaluated the results of transradial PCI performed at a tertiary 
hospital, which has progressively incorporated this technique 
to its daily clinical practice. Methods: This is a retrospective 
study of patients treated from 2007 to 2012 at Instituto Dante 
Pazzanese de Cardiologia. Clinical, angiographic and procedural 
profile and in-hospital outcomes of patients with stable and 
unstable coronary artery disease (CAD) treated with the tran-
sradial approach were compared. Results: We included 2,507 
patients, of which 72.6% had stable and 27.4% had unstable 
CAD. Patients with stable CAD had a more complex clinical 
profile, characterized by being older, more frequently females, 
with a higher incidence of comorbidities. The angiographic 
and procedural characteristics were not different for most of 
the variables analyzed. The success rate was high, but higher 
in the stable CAD group (94.6% vs. 92.4%; P = 0.05). The 
incidence of death (0.2% vs. 0.3%; P = 0.61), peri-procedural 
infarction (4.7% vs. 6.6%; P = 0.07), stroke (0.1% vs. 0.1%; 
P > 0.99), PCI (0.1% vs. 0.3%; P = 0.30), coronary artery 
bypass graft (0 vs. 0.4%; P = 0.06), major bleeding (0.2% 
vs. 0.6%; P = 0.09) or vascular complications (1% vs. 0.6%; 
P = 0.47) was low and did not differ between groups. Conclu-
sions: Transradial PCI has proved to be safe and effective in 
patients with stable and unstable CAD, treated at a tertiary 
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RESUMO
Comparação da Intervenção Coronária Percutânea 
por Via Radial em Pacientes com Doença Arterial 
Coronária Estável e Instável
Introdução: A intervenção coronária percutânea (ICP) por via 
radial ainda é pouco utilizada em nosso meio. Avaliaram-se 
aqui os resultados da ICP por via radial, realizada em um 
hospital terciário, que, progressivamente, tem incorporado tal 
técnica à prática clínica diária. Métodos: Estudo retrospectivo, 
de pacientes tratados entre 2007 e 2012, no Instituto Dante 
Pazzanese de Cardiologia. Compararam-se os perfis clínico, 
angiográfico e do procedimento e os resultados hospitalares 
dos pacientes tratados por via radial com doença arterial 
coronária (DAC) estável e instável. Resultados: Foram incluídos 
2.507 pacientes, sendo 72,6% portadores de DAC estável e 
27,4% de DAC instável. Os pacientes portadores de DAC 
estável tinham perfil clínico mais complexo, caracterizado 
por serem mais idosos, mais frequentemente do sexo feminino 
e com maior incidência de comorbidades. As características 
angiográficas e do procedimento não mostraram diferenças 
na maioria das varáveis analisadas. A taxa de sucesso foi el-
evada, porém maior no grupo DAC estável (94,6% vs. 92,4%; 
P = 0,05). A incidência de óbito (0,2% vs. 0,3%; P = 0,61), 
infarto periprocedimento (4,7% vs. 6,6%; P = 0,07), acidente 
vascular cerebral (0,1% vs. 0,1%; P > 0,99), ICP (0,1% vs. 
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hospital that has progressively incorporated this technique to 
its daily practice.
 
 
 
 
DESCRIPTORS: Angioplasty. Radial artery. Angina, stable. 
Acute coronary syndrome.
(stable angina or silent ischemia) and unstable CAD 
(with or without ST-segment elevation), treated with 
PCI by radial approach with 6F catheter at Instituto de 
Cardiologia Dante Pazzanese, São Paulo, Brazil, from 
December of 2007 to October of 2012.
Data from hospital outcomes were entered on a 
standardized form, comprising clinical, angiographic, 
and procedural characteristics, in addition to the clinical 
evolution of the patient until discharge.
Procedure
Through wrist hyperextension and infiltration of 1-2 
mL of 2% xylocaine, the radial artery was punctured 
1 cm proximal to the radial styloid process using a 
needle with a polyethylene catheter (Jelco® nº 20-22) 
and using the Seldinger technique. After the puncture, 
a 0.021-inch guidewire was introduced, followed by a 
small skin incision with a scalpel blade and insertion 
of a 6F sheath. A solution containing 5,000 IU hepa-
rin sulphate was administered through the sheath. At 
the end of the procedure, the sheath was immediately 
removed, and hemostasis was obtained with a compres-
sion band, the TR BandTM (Terumo Medical – Tokyo, 
Japan). A clinical examination of the puncture site and 
an evaluation of the radial pulse were performed at the 
time of hospital discharge.
Definitions
Angiographic success was defined as a reduction 
of the target lesion to a stenosis diameter < 30%, with 
maintenance or restoration of the normal antegrade flow 
(Thrombolysis in Myocardial Infarction [TIMI] 3).14-16 
Procedural success was considered when angiographic 
success and the absence of major clinical complica-
tions (death, nonfatal myocardial infarction [MI], or 
emergency coronary artery bypass graft [CABG] surgery) 
were obtained.
MI associated with the procedure was defined as 
the development of new Q waves and/or elevation of 
CK-MB (> three times the baseline level).
Vascular complications were defined as presence 
of hematoma > 10 cm at the site of arterial puncture; 
major bleeding, characterized as a fall in hemoglobin 
0,3%; P = 0,30), cirurgia de revascularização miocárdica (0 
vs. 0,4%; P = 0,06), sangramento maior (0,2% vs. 0,6%; P = 
0,09) ou complicação vascular (1% vs. 0,6%; P = 0,47) foi 
baixa e não diferiu entre os grupos. Conclusões: ICP por via 
radial mostrou-se segura e eficaz, tanto em pacientes com 
DAC estável como instável, tratados em hospital terciário que 
progressivamente tem incorporado essa técnica à rotina diária.
DESCRITORES: Angioplastia. Artéria radial. Angina estável. 
Síndrome coronariana aguda.
T he transradial approach for percutaneous coronary intervention (PCI) was originally introduced by Kiemeneij et al.1 Its benefits, including reduced 
complications of the puncture site, early ambulation, 
and diminished hospitalisation time, have been demon-
strated in several trials conducted in Brazilian centers 
and in other countries.2-10
Among all the potential benefits of this type of 
access, safety is undoubtedly the most attractive. With 
radial access, hemorrhagic and vascular complications 
(bleeding, pseudoaneurysm, arteriovenous fistula, and 
bruising) are rare and generally easily circumvented. 
However, the occurrence of complications is influenced 
by the learning curve.2,10
The transradial approach is still not routinely used 
in interventional cardiology centers for diagnostic and 
therapeutic procedures. Globally, less than 10% of the 
procedures are performed by this route.11 The Registro 
Central Nacional de Intervenções Cardiovasculares 
(Central Brazilian Registry of Cardiovascular Interven-
tions – CENIC) showed that in 2008, only 12.6% of 
the procedures were performed by this technique in 
Brazil.2 Previous trials have shown that, in the begin-
ning of the learning curve, technical failures and the 
necessity of crossover to the femoral technique are 
relatively frequent.12,13
Most trials evaluating the transradial approach 
compared to the femoral route revealed benefits in the 
presence of unstable coronary artery disease (CAD), 
especially in ST-segment elevation myocardial infarction 
(STEMI) , because these patients have greater proba-
bility of bleeding from the access route, due to the 
adjunct medication used (antiplatelet, antithrombotic, 
thrombolytic, etc.).
The aim of this study was to evaluate the in-hospital 
results of PCI by transradial approach, performed in a 
busy tertiary hospital that has progressively incorporated 
this technique into daily clinical practice, comparing 
patients with stable and unstable CAD.
METHODS
This was a retrospective study, using the database 
of a consecutive series of patients with stable CAD 
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> 3 g/dL or a need for red blood cells transfusion; 
or a need for surgical correction of complications 
(hematoma, pseudoaneurysm, or arteriovenous fistula 
formation).
Statistical analysis
The SPSS for Windows was used for statistical 
analysis. Qualitative variables were presented as abso-
lute and relative frequencies, and compared with the 
chi-squared or Fisher’s exact test. Quantitative variables 
were described as means and standard deviations. To 
test the groups, the Kolmogorov-Smirnov test was used 
to check the normality of the data. When the distribu-
tion was normal, Student’s t-test was used. Otherwise, 
the Wilcoxon test was used. The level of significance 
was set at 5%.
RESULTS
During the study period, from December of 2007 
to October of 2012, 2,507 consecutive patients were 
treated with PCI by transradial approach with 6F cath-
eter; 1,821 (72.6%) had a clinical diagnosis of stable 
CAD, and 686 (27.4%) of unstable CAD.
In the present service, there was a progressive 
increase in the use of the transradial approach for per-
forming PCI until 2010, stabiliszing in 2010 and 2011, 
and surpassing the femoral approach by 2012 (11.8% 
in 2008, 26.1% in 2009, 45.1% in 2010, 42.6% in 
2011, and 55% in 2012) (Figure 1).
Patients with stable disease had a more complex 
clinical profile, characterized by older age, female 
gender, and higher incidence of comorbidities such as 
diabetes, systemic hypertension, dyslipidaemia, chronic 
renal failure, previous MI, and previous CABG, when 
compared with those of the group with unstable CAD 
(Table 1).
Regarding angiographic characteristics, most analyzed 
variables showed no differences between groups. Ap-
proximately one-third of the population had involvement 
of two or three vessels, and the left anterior descending 
artery was the most frequently treated vessel. The char-
acteristics of the procedure also showed no differences 
in the diameter and length of the stent used. The use 
of glycoprotein IIb/IIIa inhibitors was sparse, and was 
more frequent in the unstable CAD group (Table 2).
The in-hospital outcomes are shown in Table 3. 
The success rate was high in both groups, but higher 
among patients with stable CAD (94.6% vs. 92.4%; 
P = 0.05). The death rate was low and did not differ 
between groups (0.2% vs. 0.3%; P = 0.61), as did rates 
of periprocedural MI (4.7% vs. 6.6%; P = 0.07), stroke 
(0.1% vs. 0.1%; P > 0.99), PCI (0.1% vs. 0.3%, P = 
0.30), CABG (0.4% vs. 0%; P = 0.06), major bleeding 
(0.2% vs. 0.6%; P = 0.09), or vascular complications 
(1% vs. 0.6%; P = 0.47). There was a lower incidence 
of nephropathy induced by contrast in the stable CAD 
group (2.1% vs. 4.1%; P = 0.01), whereas in the unstable 
CAD group a greater number of ad hoc interventions 
occurred, which justifies the higher volume of contrast 
in this group.
The hospital stay was significantly lower in the 
group with stable CAD (1.6 ± 9.1 days vs. 4.9 ± 42.7 
days; P < 0.01). 73% of all patients were discharged 
the next day after the procedure.
Figure – Percentage of use of radial and femoral techniques from 
2008 to 2012.
TABLE 1 
Demographic and clinical characteristics
Stable CAD  
(n = 1,821)
Unstable CAD 
(n = 686) P
Age, mean 61.3 ± 10.0 59.1 ± 10.7 < 0.01
Females, % 26 20.8 < 0.01
Diabetes mellitus, % 34.3 24.1 < 0.01
Hypertension, % 87.9 81.8 < 0.01
Dyslipidaemia, % 72.1 59.2 < 0.01
Smoking, % 17.7 27.8 < 0.01
COPD, % 2.7 1.9 0.31
Chronic renal failure, % 24.2 18.5 < 0.01
Prior myocardial 
infarction, % 
41.2 31.8 < 0.01
Previous PCI, % 11.8 11.5 0.88
Previous CABG, % 6.2 3.6 0.01
Prior stroke, % 1.4 1.6 0.71
CAD = coronary artery disease; COPD = chronic obstructive 
pulmonary disease; PCI = percutaneous coronary intervention; 
CABG = coronary artery bypass grafting.
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DISCUSSION
The main finding of the present study was that 
the transradial approach used in clinical practice in a 
tertiary hospital is safe and effective, both in patients 
with stable CAD and with unstable CAD. This access 
TABLE 2 
Angiographic and procedural characteristics
Stable CAD  
(n = 1,821)
Unstable CAD 
(n = 686) P
Extent of disease, % 0.26
One vessel 64.7 66.4
Two vessels 29.9 27
Three vessels 5.3 6.6
Treated vessel, % < 0.01
LAD 38.9 41.4
LCx 26.8 17.3
RC 33.6 40.7
LMCA 0.78 0.64
Saphenous graft, % 0.8 1.6 0.80
Bifurcation lesion, % 16.8 14.3 0.13
Stent diameter, mm 3.03 ± 0.42 3.08 ± 0.42 0.06
Stent length, mm 20.7 ± 6.8 20.5 ± 6.4 0.75
GPI IIb/IIIa, % 1 6.7 < 0.01
Contrast volume, mL 81.4 ± 38.3 147.5 ± 48.9 < 0.01
CAD = coronary artery disease; LAD = left anterior descending, 
LCx = left circumflex artery; RC = right coronary artery; LMCA = 
left main coronary artery; GPI = glycoprotein receptor inhibitor.
TABLE 3 
In-hospital outcomes
Stable CAD  
(n = 1,821)
Unstable CAD 
(n = 686) P
Clinical success, % 94.6 92.4 0.05
Death, % 0.2 0.3 0.61
Myocardial 
infarction, % 
4.7 6.6 0.07
Stroke, % 0.1 0.1 > 0.99
New PCI, % 0.1 0.3 0.30
CABG, % 0 0.4 0.06
Major bleeding, % 0.2 0.6 0.09
Vascular 
complications, % 
1 0.6 0.47
Renal failure, % 2.1 4.1 0.01
Length of stay, days 1.6 ± 9.1 4.9 ± 42.7 < 0.01
CAD = coronary artery disease; PCI = percutaneous coronary 
intervention; CABG = coronary artery bypass grafting.
point minimizes the risk of bleeding and vascular 
complications, equalising such different populations, 
despite the adjunctive medication used.
The transradial approach is associated with a 
dramatic reduction in the risk of complications of the 
approach route when compared to the transfemoral 
route. Growing evidence in several trials demonstrate 
a significant reduction in major adverse cardiovascular 
events when the transradial approach is used, mainly 
in the STEMI scenario.17 The transradial approach is 
particularly attractive in primary PCI, when this tech-
nique is performed by experienced surgeons, since these 
patients are treated with a more aggressive antiplatelet 
and antithrombotic regimen, resulting in a reduction 
of bleeding complications and, subsequently, of major 
adverse cardiovascular events.
Specifically in the treatment of unstable CAD, Ro-
magnoli et al.18 demonstrated that, in 30 days, the use 
of the radial access reduced the cardiovascular death, 
incidence of bleeding, and length of hospital stay, findings 
similar to those observed in a meta-analysis involving 
21 trials and 8,534 patients.19 The analysis of the same 
population, in the RIVAL trial, also demonstrated benefit 
in reducing the mortality, but this finding was limited 
to the subgroup with ST-segment elevation.17
This study also showed a reduced incidence of 
bleeding and vascular complications related to the radial 
route, as was previously demonstrated in a number of 
trials published recently.5,6,17
In this study of a real-world population, it was 
shown that the choice of the radial access for PCI still 
is less used than the femoral access, but now accounts 
for nearly half of all interventions at this institution, 
reflecting the progressive incorporation of the knowledge 
acquired with the method.
Limitations of the study
This was a retrospective, observational, single-center 
study, with all the limitations inherent in this type of 
study, in which the decision with respect to the approach 
used was responsibility of the surgeon, based on the 
experience acquired, clinical profile of the patient, and 
vascular condition of the site. However, for the same 
reasons, this may have been the best way to reproduce 
the daily practice of a coronary intervention laboratory.
CONCLUSIONS
The use of percutaneous coronary intervention by 
transradial approach was safe and effective, both in 
patients with stable and unstable coronary artery disease 
treated at a tertiary care hospital that has progressively 
incorporated this technique into daily clinical practice. 
This entry point minimized the risk of bleeding and 
vascular complications, equalising such distinct popu-
lations, regardless of the adjunctive medication used.
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